BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 168580)

  • 21. Modulation of TL (thymus-leukemia) antigens by Fab-fragments of TL antibody.
    Lamm ME; Boyse EA; Old LJ; Lisowska-Bernstein B; Stockert E
    J Immunol; 1968 Jul; 101(1):99-103. PubMed ID: 4173941
    [No Abstract]   [Full Text] [Related]  

  • 22. Quantitative isolation of mouse thymus leukemia antigen, TL.
    Stanton TH; Bennett JC; Wolcott M
    Tissue Antigens; 1976 Mar; 7(3):158-64. PubMed ID: 936201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo modulation of thymus-leukemia antigens on mouse leukemia cells and thymocytes: retention of modulating antibody on the cell surface.
    Jacobson JB; Galuska S; Stackpole CW
    J Natl Cancer Inst; 1978 Sep; 61(3):819-25. PubMed ID: 80455
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum requirements for in vivo modulation of thymus-leukemia antigens on mouse leukemia cells and thymocytes.
    Stackpole CW
    J Natl Cancer Inst; 1979 Jun; 62(6):1529-36. PubMed ID: 312352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoprotective capability of somatic hybrid cells in comparison with parental tumor cells maintained in vitro.
    Mizushima Y; Cohen EP
    Tohoku J Exp Med; 1985 Apr; 145(4):447-53. PubMed ID: 4024076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thymus-repopulating capacity of cells that can be induced to differentiate to T cells in vitro.
    Komure K; Goldstein G; Boyse EA
    J Immunol; 1975 Jul; 115(1):195-8. PubMed ID: 50347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquisition of chick cytosol thymidine kinase activity by thymidine kinase-deficient mouse fibroblast cells after fusion with chick erythrocytes.
    Kit S; Leung WC; Jorgensen G; Trkula D; Dubbs DR
    J Cell Biol; 1974 Nov; 63(2 Pt 1):505-14. PubMed ID: 4371156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigenic modulation in vitro. I. Fate of thymus-leukemia (TL) antigen-antibody complexes following modulation of TL antigenicity from the surfaces of mouse leukemia cells and thymocytes.
    Stackpole CW; Jacobson JB; Lardis MP
    J Exp Med; 1974 Oct; 140(4):939-53. PubMed ID: 4610077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Isoantigens of the H-2 and Tla loci of the mouse: interactions affecting their representation on thymocytes.
    Boyse EA; Stockert E; Old LJ
    J Exp Med; 1968 Jul; 128(1):85-95. PubMed ID: 5662018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A notable phenomenon recapitulated. A fusion product of a murine lymphoma cell and a leukemia virus-neutralizing antibody-producer host plasma cell formed spontaneously and secreting the specific antibody continuously.
    Sinkovics JG
    Acta Microbiol Immunol Hung; 2005; 52(1):1-40. PubMed ID: 15957233
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Tla locus: a new allele and antigenic specificity.
    Flaherty L; Sullivan K; Zimmerman D
    J Immunol; 1977 Aug; 119(2):571-5. PubMed ID: 69663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expression of theta-like antigen by rat peripheral lymphocytes: serologic and functional studies.
    Douglas TC; Dowsett AP
    J Immunol; 1975 Jul; 115(1):283-8. PubMed ID: 1151060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukemia X fibroblast hybrid cells prolong the lives of leukemic mice.
    Wang DR; Slomski R; Cohen EP
    Eur J Cancer Clin Oncol; 1985 May; 21(5):637-43. PubMed ID: 3159580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of specific antiserum on the metabolism of membrane antigens of somatic hybrids of murine leukemia cells.
    Liang W; Cohen EP
    J Natl Cancer Inst; 1977 Jun; 58(6):1601-8. PubMed ID: 559099
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on the effect of specific antisera on the metabolism of cellular antigens. II. The synthesis and degradation of TL antigens of mouse cells in the presence of TL antiserum.
    Yu A; Cohen EP
    J Immunol; 1974 Apr; 112(4):1296-307. PubMed ID: 4360860
    [No Abstract]   [Full Text] [Related]  

  • 36. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements.
    Tsujimura K; Takahashi T; Iwase S; Matsudaira Y; Kaneko Y; Yagita H; Obata Y
    J Immunol; 1998 Jun; 160(11):5253-61. PubMed ID: 9605121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sendai produced somatic cell hybrids between L cell strains and between liver and L cells.
    Coon HG; Weiss MC
    Wistar Inst Symp Monogr; 1969; 9():83-96. PubMed ID: 4335392
    [No Abstract]   [Full Text] [Related]  

  • 38. Complement-mediated antiserum cytotoxic reactions to human chromosome 7 coded antigen(s): immunoselection of rearranged human chromosome 7 in human-mouse somatic cell hybrids.
    Knowles BB; Solter D; Trinchieri G; Maloney KM; Ford SR; Aden DP
    J Exp Med; 1977 Feb; 145(2):314-26. PubMed ID: 188970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosomally depleted interspecific hybrid cell clones selected with cytotoxic antisera: utilization in the study of control of murine leukemia virus host-range.
    Collins JJ; Destree AT; Marshall CJ; Bernstein A; Macpherson IA
    J Supramol Struct; 1976; 4(1):71-88. PubMed ID: 176536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of the thymus-leukemia (TL) antigen in the thymus of mouse embryos.
    Schlesinger M; Hurvitz D
    Isr J Med Sci; 1968; 4(6):1210-5. PubMed ID: 5728807
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.